KRAS and Miyoshi myopathy: To identify potential serine/threonine phosphorylation sites that control KRAS stability in MM, we generated eight S/T to A mutants on the mNG-KRASG12D-IRES-Lyt2 backbone based on previously characterized phosphorylation sites28 (Fig. 2A).